Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 46 AL 60

Drug development status for Alzheimer's disease: present scenario

Misra S, Medhi B.

Neurol Sci. 2013 Jun;34(6):831-9. doi: 10.1007/s10072-013-1316-x. Epub 2013 Feb 8.

The missing link in the amyloid cascade of Alzheimer's disease - metal ions

Tiiman A, Palumaa P, Tõugu V.

Neurochem Int. 2013 Mar;62(4):367-78. doi: 10.1016/j.neuint.2013.01.023. Epub 2013 Feb 6.

[Blood-brain barrier and Alzheimer's disease]

Kuwahara H, Nishida Y, Yokota T.

Brain Nerve. 2013 Feb;65(2):145-51.

Targeting nascent soluble Aβ42 for potential Alzheimer drug development

Zhang M, Hausmann L, Song W.

J Neurochem. 2013 May;125(3):329-31. doi: 10.1111/jnc.12156. Epub 2013 Feb 13.

TREM2 in Alzheimer's disease

Jiang T, Yu JT, Zhu XC, Tan L.

Mol Neurobiol. 2013 Aug;48(1):180-5. doi: 10.1007/s12035-013-8424-8. Epub 2013 Feb 14.

Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease

Noetzli M, Eap CB.

Clin Pharmacokinet. 2013 Apr;52(4):225-41. doi: 10.1007/s40262-013-0038-9.

Alzheimer's disease and antioxidant therapy: how long how far?

Teixeira J, Silva T, Andrade PB, Borges F.

Curr Med Chem. 2013;20(24):2939-52. doi: 10.2174/1871523011320240001.

Multitarget drugs of plants origin acting on Alzheimer's disease

Russo P, Frustaci A, Del Bufalo A, Fini M, Cesario A.

Curr Med Chem. 2013;20(13):1686-93. doi: 10.2174/0929867311320130008.

Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease

Carrillo MC, Brashear HR, Logovinsky V, Ryan JM, Feldman HH, Siemers ER, Abushakra S, Hartley DM, Petersen RC, Khachaturian AS, Sperling RA.

Alzheimers Dement. 2013 Mar;9(2):123-131.e1. doi: 10.1016/j.jalz.2012.12.004. Epub 2013 Feb 12.

Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration

Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S, Glatzel M.

FEBS J. 2013 Sep;280(18):4338-47. doi: 10.1111/febs.12196. Epub 2013 Mar 13.

Food for thought: the role of appetitive peptides in age-related cognitive decline

Fadel JR, Jolivalt CG, Reagan LP.

Ageing Res Rev. 2013 Jun;12(3):764-76. doi: 10.1016/j.arr.2013.01.009. Epub 2013 Feb 13.

The role of nutrition and diet in Alzheimer disease: a systematic review

Shah R.

J Am Med Dir Assoc. 2013 Jun;14(6):398-402. doi: 10.1016/j.jamda.2013.01.014. Epub 2013 Feb 16.

Donepezil treatment stabilizes functional connectivity during resting state and brain activity during memory encoding in Alzheimer's disease

Solé-Padullés C, Bartrés-Faz D, Lladó A, Bosch B, Peña-Gómez C, Castellví M, Rami L, Bargalló N, Sánchez-Valle R, Molinuevo JL.

J Clin Psychopharmacol. 2013 Apr;33(2):199-205. doi: 10.1097/JCP.0b013e3182825bfd.

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012)

Belluti F, Rampa A, Gobbi S, Bisi A.

Expert Opin Ther Pat. 2013 May;23(5):581-96. doi: 10.1517/13543776.2013.772983. Epub 2013 Feb 21.

Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study

Li CH, Pollock BG, Lyketsos CG, Vaidya V, Drye LT, Kirshner M, Sorisio D, Bies RR; DIADS-2 Research Group.

J Clin Pharmacol. 2013 Feb;53(2):234-9. doi: 10.1177/0091270012445793. Epub 2013 Jan 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias